FDA Expands Label for Abrocitinib to Include Adolescents With … – MD Magazine

eczemarelief
3 years ago
Share



FDA Expands Label for Abrocitinib to Include Adolescents With …  MD Magazine



Source link

Tags: Abrocitinib, Adolescents, Expands, FDA, Include, Label, Magazine
Leave a Comment
Previous Article
Line scanning system developed for life science applications – Imaging and Machine Vision Europe
Next Article
Atopic Dermatitis Considerations With Peter Lio, MD – Dermatology Times

You Might also Like

Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema – TipRanks
eczemarelief July 31, 2025
Abrocitinib Effective for Atopic Dermatitis Patients Unresponsive to Biologics
eczemarelief June 20, 2024
Post Comment